Your browser doesn't support javascript.
loading
Update of recommendations for the management of COVID-19 in patients with haematological malignancies, haematopoietic cell transplantation and CAR T therapy, from the 2022 European Conference on Infections in Leukaemia (ECIL 9).
Cesaro, Simone; Mikulska, Malgorzata; Hirsch, Hans H; Styczynski, Jan; Meylan, Sylvain; Cordonnier, Catherine; Navarro, Davide; von Lilienfeld-Toal, Marie; Mehra, Varun; Marchesi, Francesco; Besson, Caroline; Masculano, Raul Cordoba; Beutel, Gernot; Einsele, Herman; Maertens, Johan; de la Camara, Rafael; Ljungman, Per; Pagano, Livio.
Afiliação
  • Cesaro S; Paediatric Haematology-Oncology, Department of Mother and Child, Azienda Ospedaliera Universitaria Integrata, Verona, Italy. simone.cesaro@aovr.veneto.it.
  • Mikulska M; Division of Infectious Diseases, Department of Health Sciences (DISSAL), University of Genova, Genova, Italy.
  • Hirsch HH; IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Styczynski J; Transplantation & Clinical Virology, Department of Biomedicine, University of Basel, Basel, Switzerland.
  • Meylan S; Clinical Virology, Laboratory Medicine, University Hospital Basel, Basel, Switzerland.
  • Cordonnier C; Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland.
  • Navarro D; Department of Paediatric Haematology and Oncology, Jurasz University Hospital, Nicolaus Copernicus University Torun, Collegium Medicum, Bydgoszcz, Poland.
  • von Lilienfeld-Toal M; Infectious Diseases Service, Internal Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Mehra V; Haematology Department, Henri Mondor Hospital, APHP, and University Paris Est-Créteil, Paris, France.
  • Marchesi F; Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.
  • Besson C; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.
  • Masculano RC; Department of Microbiology, School of Medicine, University of Valencia, Valencia, Spain.
  • Beutel G; Klinik fur Innere Medizin II (Haematologie/Oncologie), Universitatsklinikum Jena, Jena, Germany.
  • Einsele H; Leibniz Institute for Natural Product Research and Infection Biology, Hans Knöll Institute, Jena, Germany.
  • Maertens J; Department of Haematology, King's College Hospital NHS Foundation Trust, London, United Kingdom.
  • de la Camara R; Haematology Unit, Department of Research and Clinical Oncology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Ljungman P; Fundacion Jimenez Diaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain.
  • Pagano L; Department for Haematology, Haemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Leukemia ; 37(9): 1933-1938, 2023 09.
Article em En | MEDLINE | ID: mdl-37460673
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia / Transplante de Células-Tronco Hematopoéticas / Neoplasias Hematológicas / Receptores de Antígenos Quiméricos / COVID-19 Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia / Transplante de Células-Tronco Hematopoéticas / Neoplasias Hematológicas / Receptores de Antígenos Quiméricos / COVID-19 Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article